Sale!

Newborn Screening Panel 7 Test

420 د.إ

-11%

The “Newborn Screening Panel 7 Test” is a comprehensive screening test conducted at DNA Labs UAE, designed to identify seven genetic, metabolic, hormonal, and functional conditions that can affect a newborn’s long-term health or survival. Early detection through this panel allows for timely intervention and treatment, significantly improving the child’s quality of life. The test is performed shortly after birth and involves a simple process of collecting a few drops of blood from the baby’s heel. The cost of the Newborn Screening Panel 7 Test at DNA Labs UAE is 420 AED, making it an accessible option for parents looking to ensure their newborn’s health and well-being right from the start.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

Newborn Screening Panel 7 Test

Test Name: Newborn Screening Panel 7 Test

Test Components: G6PD, TSH, Phenylalanine, Cystic Fibrosis, 17-Hydroxyprogesterone, Galactosemia, Biotinidase

Price: 420.0 AED

Sample Condition: 1 drop of heel prick blood each on 3 spots of filter paper available from LPL. Ship refrigerated or frozen. Clinical details and drug history must accompany sample.

Report Delivery: Sample Mon through Fri by 9 am; Report Next day

Method: Fluoroimmunoassay

Test Type: Inborn errors of metabolism

Doctor: Pediatrician

Test Department: Genetic

Pre Test Information: Clinical details and drug history must accompany sample.

Test Details

The Newborn Screening Panel 7 Test is a screening test that is performed on newborn babies shortly after birth. It is designed to detect certain genetic, metabolic, and hormonal disorders that may not be apparent at birth but can cause serious health problems if left untreated.

The panel typically includes the following tests:

  1. Phenylketonuria (PKU): This test checks for an enzyme deficiency that can lead to a buildup of phenylalanine in the blood, causing intellectual disability if not treated early.
  2. Congenital hypothyroidism: This test checks for low levels of thyroid hormone, which can cause developmental delays if not treated early.
  3. Galactosemia: This test checks for an enzyme deficiency that can cause problems with the breakdown of galactose, a sugar found in milk. If not treated early, it can lead to liver damage and other complications.
  4. Sickle cell disease: This test checks for a genetic disorder that affects the red blood cells and can cause anemia and other complications.
  5. Cystic fibrosis: This test checks for a genetic disorder that affects the lungs and digestive system, causing respiratory and digestive problems.
  6. Severe combined immunodeficiency (SCID): This test checks for a group of rare disorders that affect the immune system, making babies susceptible to severe infections.
  7. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: This test checks for an enzyme deficiency that can lead to problems with breaking down certain fats for energy, potentially causing low blood sugar and other complications.

These tests are typically performed using a small blood sample taken from the baby’s heel. If any of the tests come back positive, further diagnostic testing may be recommended to confirm the diagnosis. Early detection and treatment of these conditions can greatly improve the long-term health outcomes for affected babies.

Test Name NEWBORN SCREENING PANEL 7 Test
Components *G6PD*TSH*Phenylalanine*CysticFibrosis *17-Hydroxyprogesterone*Galactosemia *Biotinidase
Price 420.0 AED
Sample Condition 1 drop of heel prick blood each on 3 spots of filter paper available from LPL. Ship refrigerated or frozen. Clinical details and drug history must accompany sample.
Report Delivery Sample Mon through Fri by 9 am; Report Next day
Method Fluoroimmunoassay
Test type Inborn errors of metabolism
Doctor Pediatrician
Test Department: GENETIC
Pre Test Information Clinical details and drug history must accompany sample.
Test Details

The Newborn Screening Panel 7 Test is a screening test that is performed on newborn babies shortly after birth. It is designed to detect certain genetic, metabolic, and hormonal disorders that may not be apparent at birth but can cause serious health problems if left untreated.

The panel typically includes the following tests:

1. Phenylketonuria (PKU): This test checks for an enzyme deficiency that can lead to a buildup of phenylalanine in the blood, causing intellectual disability if not treated early.

2. Congenital hypothyroidism: This test checks for low levels of thyroid hormone, which can cause developmental delays if not treated early.

3. Galactosemia: This test checks for an enzyme deficiency that can cause problems with the breakdown of galactose, a sugar found in milk. If not treated early, it can lead to liver damage and other complications.

4. Sickle cell disease: This test checks for a genetic disorder that affects the red blood cells and can cause anemia and other complications.

5. Cystic fibrosis: This test checks for a genetic disorder that affects the lungs and digestive system, causing respiratory and digestive problems.

6. Severe combined immunodeficiency (SCID): This test checks for a group of rare disorders that affect the immune system, making babies susceptible to severe infections.

7. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: This test checks for an enzyme deficiency that can lead to problems with breaking down certain fats for energy, potentially causing low blood sugar and other complications.

These tests are typically performed using a small blood sample taken from the baby’s heel. If any of the tests come back positive, further diagnostic testing may be recommended to confirm the diagnosis. Early detection and treatment of these conditions can greatly improve the long-term health outcomes for affected babies.